Brind.

RedHill Biopharma Ltd., headquartered in Tel Aviv, is a company publicly traded on the Nasdaq exchange with its lead product approved by the FDA.

4 reports, 2 independent Updated 00:00
Still developing
Reports
4
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

RedHill Biopharma Ltd., headquartered in Tel Aviv, is a company publicly traded on the Nasdaq exchange with its lead product approved by the FDA.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Tim Bull is leading studies for RedHill Biopharma.1 source
  2. RedHill Biopharma (Tel Aviv HQ) is publicly traded on Nasdaq and has FDA approval for its lead product.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped